This is a proposal from the Department of Ophthalmology and Visual Sciences at the University of Illinois at Chicago (UIC) to establish the UIC-NEI K12/Independent Clinician Vision Scientist (ICVS) Development Program. The proposed program takes a needs-assessment approach to identify the barriers to achieving independence that confront clinicians who have demonstrated the skills needed to become independent clinician scientists and designs a K12 training program to address those needs. The program recognizes that immersion in research under the guidance of excellent mentors is a key ingredient for investigator transition to independence. Therefore, the Department proposes the K-12 curriculum for mentoring scholars who have demonstrated readiness to be immersed in a research project. UIC-NEI K12/Independent Clinician Vision Scientist (ICVS) Development Program aims to provide an academically-rich and supportive environment to enable qualified early-stage clinician vision scientists to engage in a structured and mentored learning experience that will facilitate career advancement and enable trainees to become independent scientists. The program has two goals: Goal I is to establish a public university-public health agency partnership to train independent clinician vision scientists (ICVS);Goal II is to provide scientific development, authentic mentorship and professional development of the UIC-NEI K12/ICVS scholars and ensure their transition to independence. Achievement of these goals will enable UIC-NEI K12/ICVS Development Program scholars to transition to independence become national leaders in vision health research, and to become the educators, mentors, and role models for a new generation of vision health researchers.
Program Narrative The Department of Ophthalmology and Visual Sciences at the University of Illinois at Chicago (UIC) proposes to establish the UIC-NEI K12/ICVS Development Program. The program aims to provide an academically-rich and supportive environment that will give early -stage clinician vision scientists a mentored learning experience that will facilitate their career advancement and to become independent scientists.
|Eslani, Medi; Putra, Ilham; Shen, Xiang et al. (2018) Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function. Stem Cells 36:775-784|
|Lobo, Ann-Marie; Agelidis, Alex M; Shukla, Deepak (2018) Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf :|
|Ali, Mohsin H; Azar, Nathalie F; Aakalu, Vinay et al. (2018) Congenital cavitary optic disc anomaly and Axenfeld's anomaly in Wolf-Hirschhorn syndrome: A case report and review of the literature. Ophthalmic Genet 39:271-274|
|Sun, Michael G; Rojdamrongratana, Duangmontree; Rosenblatt, Mark I et al. (2018) 3D printing for low cost, rapid prototyping of eyelid crutches. Orbit :1-5|
|Lobo, Ann-Marie; Gao, Yan; Rusie, Laura et al. (2018) Association between eye diagnosis and positive syphilis test results in a large, urban sexually transmitted infection/primary care clinic population. Int J STD AIDS 29:357-361|
|Park, Jason C; Moss, Heather E; McAnany, J Jason (2018) Electroretinography in idiopathic intracranial hypertension: comparison of the pattern ERG and the photopic negative response. Doc Ophthalmol 136:45-55|
|Boven, Lindsay; Jiang, Qin Li; Moss, Heather E (2017) Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis. Neuroophthalmology 41:310-314|
|Boven, Lindsay C; Jiang, Qin Li; Moss, Heather E (2017) Validation of Simplified Visual Acuity Testing Protocols in Amyotrophic Lateral Sclerosis. Neuroophthalmology 41:247-252|
|Baradaran-Rafii, Alireza; Eslani, Medi; Haq, Zeeshan et al. (2017) Current and Upcoming Therapies for Ocular Surface Chemical Injuries. Ocul Surf 15:48-64|
|Andreoli, Michael T; Chau, Felix Y; Shapiro, Michael J et al. (2017) Epidemiological trends in 1452 cases of retinoblastoma from the Surveillance, Epidemiology, and End Results (SEER) registry. Can J Ophthalmol 52:592-598|
Showing the most recent 10 out of 55 publications